BlackRock, Inc.

Position in ELAN — Elanco Animal Health Inc

CIK 2012383 New York, NY

Position in ELAN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,202,197,829

+$62,588,302 QoQ

Shares Held

48,849,973

+2.6% QoQ

Ownership

9.78%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 515 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $21,635,633,053 across 65 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	5,294,529	$2,868,734,637
2	ZTS	Zoetis Inc.	39,430,181	$2,833,452,797
3	NBIX	Neurocrine Biosciences Inc	13,711,607	$2,310,954,234
4	TEVA	Teva Pharmaceutical Industries Ltd	63,894,301	$2,164,738,910
5	ALKS	Alkermes plc.	29,235,739	$1,531,952,715
6	VTRS	Viatris Inc	86,019,468	$1,365,989,144
7	ELAN	Elanco Animal Health Inc This page	48,849,973	$1,202,197,829
8	HIMS	Hims & Hers Health, Inc.	28,703,514	$995,150,823

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,202,197,829	48,849,973	+2.6%	Shares	Sole	2026-08-07
2026-03-31	$1,139,609,527	47,622,630	+2.8%	Shares	Sole	2026-05-13
2025-12-31	$1,048,570,023	46,335,397	+0.3%	Shares	Sole	2026-02-12
2025-09-30	$930,035,022	46,178,502	+100.2%	Shares	Sole	2025-11-12
2025-06-30	$329,460,596	23,071,471	-2.7%	Shares	Sole	2025-08-12
2025-03-31	$249,016,358	23,715,844	-4.6%	Shares	Sole	2025-05-02
2024-12-31	$301,146,240	24,867,568	+2.3%	Shares	Sole	2025-02-07
2024-09-30	$356,987,750	24,301,413	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.